Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (5y) (2015 - 2026)
Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Oruka Therapeutics |
3.86 Bn |
3.47 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-374.53% |
| Dec 31, 2025 |
-342.37% |
| Jun 30, 2025 |
338.54% |
| Mar 31, 2025 |
577.66% |
| Dec 31, 2024 |
-1,005.31% |
| Mar 31, 2022 |
-14.88% |
| Dec 31, 2021 |
-14.90% |
| Sep 30, 2021 |
64.68% |
| Jun 30, 2021 |
73.31% |
| Mar 31, 2021 |
74.15% |
| Dec 31, 2020 |
-45.41% |
| Jun 30, 2020 |
9.71% |
| Mar 31, 2020 |
-8.45% |
| Dec 31, 2019 |
32.24% |
| Sep 30, 2018 |
22.88% |
| Mar 31, 2018 |
220.99% |
| Dec 31, 2016 |
262.92% |
| Sep 30, 2016 |
-380.07% |
| Dec 31, 2015 |
-14.96% |
